Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer

Clinical trial NCT03373760 · COMPLETED

Trial details

NCT number: NCT03373760
Sponsor: SWOG Cancer Research Network
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Squamous Cell Lung Carcinoma Stage IV Squamous Cell Lung Carcinoma AJCC v7

Start date: 2017-11-30
Primary completion: 2020-05-18
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.